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Improved detection of pulmonary nodules
on energy-subtracted chest radiographs
with a commercial computer-aided diagnosis
software: comparison with human observers
Abstract Objective: To retrospec-
tively analyze the performance of a
commercial computer-aided diagnosis
(CAD) software in the detection of
pulmonary nodules in original and
energy-subtracted (ES) chest radio-
graphs. Methods: Original and ES
chest radiographs of 58 patients with
105 pulmonary nodules measuring 5–
30 mm and images of 25 control
subjects with no nodules were rando-
mized. Five blinded readers evaluated
firstly the original postero-anterior
images alone and then together with
the subtracted radiographs. In a sec-
ond phase, original and ES images
were analyzed by a commercial CAD
program. CT was used as reference
standard. CAD results were compared
to the readers’ findings. True-positive
(TP) and false-positive (FP) findings
with CAD on subtracted and non-
subtracted images were compared.
Results: Depending on the reader’s
experience, CAD detected between 11
and 21 nodules missed by readers.
Human observers found three to 16
lesions missed by the CAD software.
CAD used with ES images produced
significantly fewer FPs than with non-
subtracted images: 1.75 and 2.14 FPs
per image, respectively (p=0.029).
The difference for the TP nodules
was not significant (40 nodules on
ES images and 34 lesions in non-
subtracted radiographs, p=0.142).
Conclusion: CAD can improve
lesion detection both on energy
subtracted and non-subtracted chest
images, especially for less experi-
enced readers. The CAD program
marked less FPs on energy-subtracted
images than on original chest
radiographs.
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Introduction
Even in the era of low-dose chest computed tomography
(CT) for lung cancer screening, chest radiography remains
the primary investigation to exclude pulmonary nodules in
many countries due to its easy application, low cost and
radiation dose [1, 2]. The overlay of bones and soft tissue
structures, such as mediastinum, pulmonary vessels and
diaphragm, is a well-known drawback of summation chest
radiography that significantly hampers the recognition of
lung lesions. Dual-energy radiography with energy sub-
traction (ES) has been developed to produce soft tissue
images of the chest and, thus, to eliminate or reduce the
disturbing effects of the ribs and the clavicles. Though the
method has been shown to improve the detection rate and
diagnostic confidence for both calcified and non-calcified
lung nodules, it can also increase the number of false-
positive (FP) findings in human observer studies [3–6].
Computer-aided detection (CAD) programs are increas-
ingly used to yield a secondary opinion in reading chest
radiographs in detecting and characterizing pulmonary
nodules [7–11]. Recently, a commercial CAD software has
been shown to mark a substantial proportion of visually
subtle lung cancers missed by radiologists on standard
postero-anterior (PA) chest radiographs [12]. Though the
combination of ES and CAD had been shown to be
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promising for detecting simulated lung nodules with an
experimental CAD system [13], we are not aware of any
published results on the behavior of commercial CAD
programs for energy-subtracted chest images in patients.
Thus, the purpose of our retrospective study was to
evaluate the performance of a commercially available CAD
program for the detection of pulmonary nodules on soft
tissue chest radiographs with special regard to the number
of FP marks and to compare the results with findings by
human observers.
Materials and methods
Patients
This retrospective study was performed according to the
regulations of the institutional review board and, thus, the
need of informed consent has been waived. Study subjects
were a subgroup of a patient collective that had been
analyzed for pulmonary lesions in a human observer study
[6]. In the current investigation, readers’ data were only
used for cross-reference with CAD results and to compare
the effect of ES on nodule detection by human observers
and the CAD software.
Our electronic database was searched for patients
examined with single-shot dual-ES chest radiography
between January and December 2005, with at least one
pulmonary nodule in chest CT performed within a 14-day
interval. When more than one chest radiograph was
acquired in the same patient within the 2-week period,
that radiograph taken closest to the date of the CT
examination was chosen. Patients with chest surgery
between the two examinations and three patients with
significant pleural effusion obscuring at least two-thirds of
one hemichest were excluded. The CT examinations of the
remaining 77 patients were analyzed, and the size (average
of the shortest and longest diameters) of each pulmonary
lesion was measured. These patients had been analyzed in
the primary reader study [6].
Pulmonary masses larger than 3 cm are usually obvious
in chest radiographs not requiring CAD assistance. On the
other hand, lung nodules smaller than 5 mm are hardly
visible on conventional radiographs [14] and, if inciden-
tally discovered, are rather insignificant with an estimated
malignancy rate of only 1% [15–18]. Additionally, more
than five pulmonary nodules probably do not have an
impact on therapeutic decision. Therefore, only subjects
with no more than five pulmonary nodules measuring
between 5 and 30 mm were included in the current series
and patients with pulmonary masses ≥3 cm (n=14) and
those with more than five lesions (n=5) were excluded
(Fig. 1). These selection criteria based on clinical
arguments corresponded best with the specifications of
the CAD software used in the study, which was optimized
to detect up to five solid pulmonary lesions measuring 9–
30 mm on PA/AP chest images. Fifty-eight patients (23
female, 35 male, mean age 62.9±13.9 years; range, 31–
94 years) met the selection criteria and were included in the
study. The diagnoses, which were proven with either
biopsy or surgery, were primary lung cancer in 27 patients,
pulmonary metastases in 23 cases and benign disease
(aspergillosis, sarcoidosis, Wegener’s granulomatosis,
hamartoma and granuloma) in eight patients.
Control subjects
The control group consisted of 25 patients (eight female, 17
male, mean age 61.8±13.1 years, range 28–89 years)
which were randomly selected from subjects undergoing
ES chest radiography and having no focal findings (i.e.,
nodule, consolidation, atelectasis and ground glass opacity)
at chest CT within a 2-week interval in the study period.
Digital radiography and chest CT
PA single-shot dual-energy radiography of the chest was
performed on a Fuji XU-D1 (Fujifilm Medical, Tokyo,
Japan) upright imaging system. The X-ray tube potential
was set at 125 kVp at a constant focus-detector distance of
2 m. Tube current was selected automatically by the unit at
a reference dose of 3.5 μGy. The spatial resolution was 5
pixels/mm, equaling 2,140×1,760 pixels per image with a
format of 43×35 cm. Lateral view radiographs, which had
Fig. 1 Selection process for the study population
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routinely been taken in all subjects, were not used in the
study since the CAD software had been developed for PA
chest images.
All chest CT examinations were performed on a Siemens
Somatom Cardiac 64 multidetector system (Siemens
Medical Solutions, Forchheim, Germany) using a tube
rotation time of 0.5 s, a collimation of 24×1.2 mm, pitch of
1.125 and continuous image reconstruction at 2 mm and
5 mm. In both patient and control groups, 80 ml iodinated
contrast agent (Ioversol, Optiray 350; Tyco Healthcare/
Mallinckrodt, St. Louis, Mo.) was administered intrave-
nously in an antecubital vein at a flow rate of 3–4 ml/s.
All images were stored in a picture archiving and
communication system (PACS).
Image analysis by human observers
The PA chest radiographs of 83 study subjects were
anonymized and images with or without lung nodules were
shown to readers in a randomized order. Image analysis
was performed on two high-resolution liquid crystal
display (LCD) monitors (ME355i2; Totoku Electric,
Japan) by five radiologists with a professional experience
of 0.5–30 years and with experience of 2 months to 2 years
with ES. The observers marked suspicious localizations on
evaluation sheets especially designed for this study. As in
clinical situations, readers first analyzed the non-subtracted
radiographs and then the soft tissue images in the same
session. After marking suspicious localizations on the
original radiograph, observers were not allowed to correct
marks in retrospect after having seen the subtracted image.
Image analysis with CAD software
Non-subtracted and soft tissue PA chest radiographs of all
subjects were analyzed by a CAD software (OnGuard
Version 4.0, Riverain Medical, Miamisburg, Ohio), which
is commercially available in Europe and pending Food and
Drug Administration approval in the United States. The
software marked up to five suspicious areas in each image
by placing circular regions of interest (ROIs) with a radius
of 2.5 cm.
Data analysis and statistics
Marks made by the readers and the CAD software were
compared with the CT findings by the conductor of the
study using two high-definition LCDmonitors in a side-by-
side manner. For better accuracy, 2-mm transverse CT
images at lung and soft tissue window settings as well as
multiplanar reconstructions were analyzed as necessary. A
CAD mark was rated true positive (TP) if the center of the
ROI fell within the boundaries of a pulmonary nodule
verified at CT, otherwise it was regarded as FP. Lesions
evident at CT and not marked by the radiologists or the
CAD program were rated as false negative (FN). The
underlying causes for FP findings with CAD were
identified by analyzing both the chest radiographs and
CT images at the level of the FP localization.
The study design involved both lesion localization and
multiple lesions per image. Furthermore, the CAD software
did not provide confidence rates along the marks. For these
reasons, neither the classic receiver-operating characteristic
Table 1 Statistical analysis of findings by five human observers and
a CAD software in 58 patients with 105 pulmonary nodules
confirmed on CT and 25 control subjects. For each observer and the
CAD software, the first row shows data of original chest radiographs
without ES and the second row contains numbers derived from the
energy-subtracted images. TP, FN and FP findings refer to marks or
nodules and TN findings refer to patients; therefore, specificity and
accuracy were not calculated
Reader (experience) TP FN FP TN Sensitivity (%)
Reader 1 without ES 38 67 20 20 36.2
(11 years) with ES 39 66 28 19 37.1
Reader 2 without ES 38 67 21 20 36.2
(30 years) with ES 44 61 28 19 41.9
Reader 3 without ES 27 78 44 22 25.7
(4 years) with ES 34 71 55 19 32.4
Reader 4 without ES 30 75 13 23 28.6
(7 years) with ES 34 71 12 24 32.4
Reader 5 without ES 22 83 21 21 21.0
(1/2 years) with ES 33 72 19 21 31.4
Mean all without ES 31 74 24 21 29.4
Readers with ES 37 68 28 20 35.0
CAD without ES 34 71 178 5 32.4
with ES 40 65 145 5 38.1
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methodology nor statistical methods used for the evalua-
tion of marks collected in a free-response manner could be
applied to compare performance of CAD with human
observers Thus, each pulmonary nodule was analyzed if it
was detected or missed by the readers and the CAD
software, and the results were compared using the
McNemar test. CAD findings with and without ES were
compared using the Wilcoxon matched pairs test. FP marks
with CAD in patients and control subjects were compared
with the Mann-Whitney U-test. The age and gender
distribution in the patient and control groups were
compared using the t-test for independent samples and
the chi-square test. To rule out that clustering might have
influenced the results by the human observers, the
probability of detecting nodules lying closer than 3 cm to
each other was compared with the detection probability of
disseminated nodules of the same size using the chi-square
test. This analysis was not necessary with the CAD system
since the program treats each candidate nodule independent
of other nodules in the neighborhood. Statistical analyses
Fig. 2 Original (a) and energy-subtracted (b) PA chest radiographs
and a transverse contrast enhanced CT scan (c) in a 53-year-old
woman with pulmonary metastases of a pancreatic carcinoma. Two
lesions in the left lung were correctly identified by CAD software on
both images. A third nodule measuring 9 mm in the right lower lobe
was missed on both radiographs (white arrow in b and c). CAD
marked three FP localizations on the non-subtracted radiograph and
no FP findings on the subtracted image
Fig. 3 A 67-year-old female patient with pulmonary embolism but
no nodules on chest CT (not shown). The CAD program marked
hilar vessels as a suspicious area for nodules on both the standard (a)
and energy-subtracted (b) chest radiographs. Two additional FP
locations on the original radiograph correspond to overlay of the
clavicles with ribs
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were performed with the Statistica 7 software (StatSoft,
Tulsa, Okla.); a p value <0.05 was considered significant.
Kappa-statistics were used to assess both the inter-reader
agreement and the agreement between readers and the
CAD program in a lesion-to-lesion manner (MedCalc,
Mariakerke, Belgium).
Results
The patient and control groups did not differ significantly
in respect to age (p=0.97) and gender ratio (p=0.51). A
total of 105 pulmonary nodules measuring 5–30 mm
(mean, 11.3±6.6 mm) were found in the chest CT of 58
patients. Thirty-three patients had one lesion, 11 patients
had two lesions and 14 patients had three to five lesions.
Three readers marked more FPs in the soft tissue images
compared with non-subtracted radiographs (Table 1). De-
pending on the reader’s experience, the number of FPs,
ranged from 12 to 55, corresponding to 0.14–0.66 FP
findings per image. The sensitivities ranged between 21.0
and 41.9%. The mean inter-observer agreement was good
with a kappa-value of 0.512 (range, 0.401–0.698). Cluster-
ing did not have any significant effect on the lesion detection
by the human observers, since nodules in close vicinity
(>3 cm) were detected with the same probability as
disseminated nodules of the same size (p=0.804, odds
ratio=1.19, 95% confidence interval= [0.321; 4.454]).
The CAD software detected non-significantly more true
positive nodules on the soft tissue images compared with
the non-subtracted radiographs, (p=0.142, Table 1). The
number of FP findings ranged between none and five per
image, reaching a total of 178 FPs (2.14 FPs per image) in
the original radiographs and 145 FPs (1.75 FPs per image)
in the soft tissue images (p=0.029; Figs. 2, 3). The number
of FPs with CAD was significantly higher than FPs
marked by the readers both with and without ES (p<
0.0001). The number of FP marks made by the CAD
Table 2 Lesion-by-lesion comparison of findings by readers and CAD software (+ correctly identified nodules, – missed lesions)
Reader (experience) Reader+ CAD+a Reader+ CAD–b Reader– CAD+c Reader– CAD–a Agreement (kappa)d
Reader 1 without ES 23 15 11 56 0.451
(11 years) with ES 26 13 14 52 0.452
Reader 2 without ES 22 16 12 55 0.409
(30 years) with ES 28 16 12 49 0.445
Reader 3 without ES 17 10 17 61 0.380
(4 years) with ES 19 15 21 50 0.251
Reader 4 without ES 23 7 11 64 0.596
(7 years) with ES 25 9 15 56 0.501
Reader 5 without ES 19 3 15 68 0.569
(1/2 years) with ES 27 6 13 59 0.603
Mean all without ES 21 10 13 61 0.488
Readers with ES 25 12 15 53 0.447
aConcordant findings by the readers and the CAD program
bLesions that were found by readers but missed by the CAD progam
cLesions that were found by the CAD software but missed by the readers. In these cases, CAD was potentially beneficial to avoid FN
findings
dA high kappa value simply indicates the proportion of concordant findings, i.e., lesions found or missed both by the reader and the CAD
software, and does not necessarily reflect a good diagnostic performance
Table 3 Distribution of CAD findings grouped by size of the lung lesions
Size range Number of lesions Findings without ES Findings with ES
TP FN TP FN
5–10 mm 66 4 62 6 60
10–15 mm 18 17 1 17 1
15–20 mm 9 6 3 8 1
20–25 mm 7 4 3 6 1
25–30 mm 5 3 2 3 2
Total 105 34 71 40 65
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software in patients and controls were not significantly
different (without ES, 2.27 vs 1.84 FPs per image, p=0.19;
with ES, 1.67 vs 1.92 FP per image, p=0.63). Mean
sensitivity of the observers and sensitivity of the CAD
software did not differ significantly (p=0.24 without ES,
p=0.27 with ES).
On average, 61 out of 105 lesions (58.1%) were not
detected by either the human observers or by the CAD
software in the non-subtracted radiographs; this rate was 53
out of 105 (50.5%) in the soft tissue images (Table 2).
Depending on the reader’s experience, CAD found 11–17
lesions on the original radiographs and 12–21 nodules on
subtracted images that had been missed by the readers. For
the three less-experienced radiologists (readers 3, 4 and 5),
the total number of nodules found by CAD but missed
by the readers was greater than the number of nodules
correctly identified by the human observers but missed by
CAD software (without ES, 43 vs 20 nodules, p=0.006;
with ES, 49 vs 30 nodules, p=0.043). For the more
experienced radiologists (readers 1 and 2), non-significantly
more lesions were detected by the readers only compared
with nodules found by the CAD program only (without ES,
31 vs 23, p=0.341; with ES, 29 vs 26 nodules, p=0.787).
The kappa-value for the agreement between readers and
CAD software varied between 0.251 and 0.603.
The CAD program detected 77% (30/39) of nodules
larger than 1 cm in the non-subtracted radiographs, while
this rate was 87% (34/39) in the soft tissue images. Nodules
measuring 5–10 mm were missed in 94% (62/66) on the
original and 91% (60/66) in the subtracted images
(Table 3). Although CAD found more nodules in the size
range of 15–25 mm with ES compared with non-subtracted
images, this difference failed to reach statistical signifi-
cance (14 vs 10 lesions, p=0.102).
Most FP marks made by the CAD system were attributed
to vascular structures both in standard and soft tissue
images (Table 4). In 9% of the cases, diminished quality of
ES was responsible for FP findings (Fig. 4).
Discussion
ES and the use of CAD programs are two different ways to
improve the detection of pulmonary nodules on chest
radiographs. There is no experience with the combination
of these techniques on lesion depiction in patients, and it is
unknown if ES might increase the number of FP findings
with CAD as it did for human observers [6].
Fig. 4 Example for misregistration by the CAD software on a low-
quality energy-subtracted chest radiograph (b) performed in a
60-year-old male with no focal lesions at chest CT (not shown). The
ghost of the bony structures led to four new FP marks compared
with the original radiograph (a)
Table 4 Causes for FP findings with the CAD software on chest radiographs without and with ES (NA not applicable)
Without ES, n (%) With ES, n (%)
Bones (1st sternocostal and sternoclavicular joints, superimposition of two ribs) 53 (30%) 12 (8%)
Pulmonary vessels (running orthogonal to the detector plane) 82 (46%) 65 (45%)
Lung pathologies (atelectasis, consolidation, fibrotic changes, scarring) 21 (12%) 34 (23%)
Extrapulmonal soft tissue densities (nipple, skin fold, diaphragm, pleural effusion) 11 (6%) 7 (5%)
Medical devices (pacemaker, port chamber, stopcock) 2 (1%) 3 (2%)
Low-quality subtraction NA 13 (9%)
No identifiable cause 9 (5%) 11 (8%)
Total 178 (100%) 145 (100%)
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The two primary goals of the current retrospective series
were (1) to look for pulmonary nodules missed by human
observers but detected by a commercially available CAD
program and (2) to define the rate of FP findings with the
CAD software on subtracted and non-subtracted chest
radiographs. Notably, our study design was different from
the scheme used for CAD programs in the clinical routine
as nodules were evaluated by the readers and CAD
program in two separate sessions. This was done to avoid
that CAD marks interact with the decision process of the
human observers. The analysis of the impact of CAD on
the observers’ performance will be the subject of a future
study.
Although we clearly analyzed a selected population, a
bright spectrum of patients with one to five lesions and
normal subjects with no focal findings at CTwere included
in the study. Even in this heterogeneous collective the rate
of FP marks made by the CAD software remained
acceptably low reaching only 2.14 FPs per image in
original chest X-rays and 1.75 FPs per image in the soft
tissue radiographs. Thirteen FPs were attributed to low-
quality ES and thus, were potentially avoidable. Former
series on CAD reported 5.9–15 FP lesions per image [12,
19]. The low FP rate in our study was most likely caused by
the better lesion marking algorithm of our CAD software.
The lower rate of FP findings will probably increase the
usability of the CAD systems and their acceptance among
radiologists.
The relatively low sensitivity of human observers
corresponds to the data in the literature [20–23]. Similarly,
CAD detected only about one third of all lesions. In our
series, 63% of the analyzed nodules measured 10 mm or
less, which can explain the low overall sensitivity. Not
surprisingly, the detection rate with CAD for these lesions
<10 mm in size was low both on non-subtracted and
subtracted images, reaching only 6% and 9%, respectively.
CAD with ES images detected only non-significantly more
nodules than with original images, which can be explained
by the relatively low number of lung nodules analyzed in
the study. The advantage of ES might reach statistical
significance in a larger collective.
Eleven to 21 lesions, equaling 10–20% of all nodules,
were only detected by the CAD program and missed by
individual observers. The number of lesions detected by
the readers only was higher for experienced observers than
for less experienced observers. Furthermore, the software
and the readers often identified different lesions. These
results indicate that CAD can help human observers in
lesions detection and physicians with less experience
would profit from the use of CAD software more than
experienced physicians. However, it remains open whether
the increased conspicuity of parenchymal changes as cause
for FP in subtracted images might mislead human
observers. A prospective multiobserver study comparing
the performance before and after applying the CAD
program in combination with ES is obviously necessary
to answer this question. Another interesting topic for future
investigation would be the analysis of the impact of CAD
on patient management and time needed for interpreting
images.
We conclude that, depending on the observer’s experi-
ence in interpreting chest radiographs, CAD can help in
nodule detection both on standard and energy-subtracted
images. The tested commercial CAD program produced
significantly less FP findings on energy-subtracted soft
tissue images compared with non-subtracted chest radio-
graphs, which can increase the acceptance of the technique
for routine use. Though identifying pulmonary nodules
smaller than 10 mm remains a problem, the combined use
of ES and CAD has the potential to improve sensitivity of
lesion detection on chest radiographs. We think that further
investigations are needed to analyze the clinical feasibility
of this combination and to establish its role in the daily
routine.
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